Semaglutide Side Effects Guide
Semaglutide side effects: one molecule, three products, one pattern
~15–44%
Nausea, scaling with dose
7 days
half-life, weekly forms
4–8 wks
typical settling per dose
Semaglutide comes in three retail forms: Ozempic (weekly injection, diabetes), Wegovy (weekly injection, weight management, highest dose), and Rybelsus (daily tablet), plus compounded versions in defined circumstances. The molecule is identical, so the side effects are one story told at different volumes: nausea leads (roughly 15 to 20% at diabetes doses, up to ~44% at 2.4 mg), with diarrhea, vomiting, and constipation behind it. Effects cluster after dosing and dose increases, settle within 4 to 8 weeks per level, and the serious red flags (pancreatitis, gallbladder disease, dehydration) are rare but non-negotiable same-day territory.
Highlights
Key takeaways
- 01
Product matters mainly through dose: Ozempic tops out at 2 mg, Wegovy at 2.4 mg, and the GI rates scale accordingly. Rybelsus adds tablet-specific quirks (empty-stomach ritual, more dyspepsia reports) at the same class list.
- 02
Semaglutide's 7-day half-life smooths everything: side effects rise and fall on a slope, missed doses are buffered, and full clearance after stopping takes 5 to 7 weeks.
- 03
The weekly rhythm is real: most people feel injectable semaglutide most in the 24 to 72 hours after the shot and best by mid-week.
- 04
Compounded semaglutide behaves like semaglutide when properly made; its extra risks are sourcing and dosing precision, not different pharmacology.
- 05
Under 5% of trial participants stopped over GI effects even at the highest dose. Food mechanics, fluids, and pacing manage most weeks.
- 06
One log covers all three products: dose, symptom, severity, date. Trends across weeks drive every titration and switching decision.
Semaglutide side effects across products
| Symptom | Ozempic (≤2 mg) | Wegovy (2.4 mg) | Rybelsus (oral) | Red flag |
|---|---|---|---|---|
| Nausea | ~15–20% | ~44% | ~11–20% | Can't keep fluids down |
| Diarrhea | ~8–9% | ~30% | ~9–10% | Bloody, or dehydration signs |
| Vomiting | ~5–7% | ~24% | ~6–8% | Lasts over 24 hours |
| Constipation | ~3–5% | ~23% | ~5–6% | Severe pain, distension |
| Abdominal discomfort / dyspepsia | ~5–7% | ~20% | ~10–11% | Severe, radiating to back |
Approximate rates from each product's prescribing information and pivotal programs (SUSTAIN, STEP, PIONEER); placebo arms reported far lower rates. Figures are educational, not predictions, and vary with titration pace and individual response.
One molecule, three products: what actually differs?
Ozempic, Wegovy, and Rybelsus contain the same active molecule. What differs is dose ceiling and route: Ozempic titrates to 1 or 2 mg weekly for diabetes, Wegovy climbs to 2.4 mg weekly for weight management, and Rybelsus delivers 3 to 14 mg daily as a tablet whose absorption depends on an empty-stomach ritual.
Because side effects scale with dose, Wegovy posts the highest trial numbers, Ozempic the gentler ones, and Rybelsus sits in the same family with a tablet accent: a bit more dyspepsia and nausea reporting around the daily dose. Same story, different volumes.
The semaglutide pattern: onset and duration
Injectable semaglutide follows the weekly rhythm: effects concentrate in the day or two after the shot and ease by mid-week. Within any dose level, the roughest stretch is the first two to three weeks, settling by weeks 4 to 8 as blood levels plateau. Every dose increase briefly replays a milder version.
The 7-day half-life smooths both directions: side effects never spike overnight, and they never vanish overnight either. It also buffers missed doses (catch up within 5 days per the labels; otherwise skip, never double) and stretches full clearance after stopping to 5 to 7 weeks.
Does the Rybelsus tablet change anything?
The list stays the same; the rhythm changes. A daily tablet means daily dosing effects rather than a weekly wave, and the absorption ritual (first thing, empty stomach, small sip of water, 30 minutes before anything else) is itself the most common practical complaint.
Tablet users report somewhat more dyspepsia and early nausea around dose escalations, managed the same way: slower escalation, smaller meals, steady fluids. If the morning ritual is unlivable, that is a real reason to discuss the injectable route rather than a personal failing.
What about compounded semaglutide?
Properly made compounded semaglutide is the same molecule and produces the same side-effect pattern. Its distinct risks are upstream of pharmacology: sourcing quality, added ingredients, and above all dosing precision, since vial-and-syringe dosing has produced well-documented unit-confusion errors that no branded pen allows.
If you use a compounded version, confirm your exact draw in milligrams with your prescriber, and treat any unusually strong reaction after a routine dose as a dosing question first. Our compounded GLP-1 explainer covers the sourcing questions worth asking.
Which semaglutide side effects are serious red flags?
Identical across all three products. Severe, persistent abdominal pain, especially radiating to the back or paired with unrelenting vomiting, is pancreatitis territory: same-day care. Sharp right-sided pain after fatty meals points at the gallbladder. Vomiting past 24 hours risks dehydration and kidney strain.
Combined with insulin or a sulfonylurea, watch for hypoglycemia. Sudden vision changes matter for people with diabetes. And the thyroid C-cell warning excludes anyone with personal or family history of medullary thyroid carcinoma or MEN2.
Call your doctor right away if you notice
- Severe stomach pain that won't go away, especially radiating to the back
- Vomiting lasting more than 24 hours, or fluids not staying down
- Yellowing of the skin or eyes
- Sharp right-sided pain after fatty meals, or pain with fever
- Very little urine, dizziness, or a racing heart
- Shakiness, sweating, or confusion if you also take insulin or a sulfonylurea
- Sudden changes in your vision
- Trouble breathing, or rash with swelling of the face or tongue
Managing the weeks, whichever product you use
The management playbook does not care which box the semaglutide came in:
- Small, slow, protein-first meals; low-fat and bland after dose days.
- Cold foods over hot when smells trigger queasiness.
- 2 to 3 liters of fluid daily, in small sips.
- Upright 30 to 60 minutes after meals; short walks help.
- Fiber built gradually with water, for the constipation side.
- A dated log of dose, symptom, and severity: the record every titration decision leans on.
FAQ
Frequently asked questions
What are the most common semaglutide side effects?
Nausea leads at every dose (roughly 15 to 20% at diabetes doses, up to ~44% at Wegovy's 2.4 mg), followed by diarrhea, vomiting, constipation, and abdominal discomfort. Most cases are mild to moderate and settle within 4 to 8 weeks per dose level.
Are Ozempic, Wegovy, and Rybelsus side effects different?
Same molecule, same list. Rates scale with dose (Wegovy highest), and Rybelsus adds tablet-specific notes: the empty-stomach ritual and somewhat more dyspepsia reporting. Management is identical across the three.
How long do semaglutide side effects last after stopping?
With a 7-day half-life, semaglutide takes about 5 to 7 weeks to clear after the last dose, and GI effects fade along that slope while appetite gradually returns.
Are compounded semaglutide side effects different?
Properly made, no: same molecule, same pattern. The added risks are sourcing quality and dosing precision with vials and syringes. Confirm your exact dose in milligrams with your prescriber, and treat unusual reactions as a dosing question first.
Track your Semaglutide journey on one quiet line.
Log your shot, injection site, meals, and side-effect severity together, and walk into your next appointment with a week-by-week picture instead of a guess.
Sources
- 1.Prescribing information for Ozempic, Wegovy, and Rybelsus: adverse reactions, warnings, and dosage sections. View label on DailyMed ↗
- 2.SUSTAIN, STEP, and PIONEER clinical program summaries: gastrointestinal adverse-event reporting by dose and route. Find on PubMed ↗
- 3.Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). NEJM 2021. Read on NEJM ↗
- 4.FDA communications on compounded semaglutide dosing errors and sourcing. Find on PubMed ↗
This guide is for general education and is not medical advice. It doesn't account for your personal medical history, other medications, or your individual situation, and it doesn't replace a conversation with your doctor or pharmacist. Do not start, stop, or change the dose of Semaglutide or any medication based on what you read here. If you think you have a medical emergency, call your local emergency number. DoseLog is a tracking app; drug and company names are used factually under nominative fair use, and DoseLog is not affiliated with, endorsed by, or sponsored by any manufacturer mentioned.
Keep reading
GLP-1 Side Effects Overview
GLP-1 side effects: the complete plain-language overview
Ozempic Side Effects Guide
Ozempic side effects: what to expect on the weekly semaglutide shot
Wegovy Side Effects Guide
Wegovy side effects: what the 2.4 mg dose really brings
Zepbound Side Effects Guide
Zepbound side effects: what to expect on weekly tirzepatide